Soo RA, Dafni U, Han JY, Cho BC, et al. ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial. Clin Cancer Res 2024;30:5180-5191.
PMID: 39250635